Top Markets
Coin of the day
Artemis Therapeutics Inc. Artemis Therapeutics Inc.

Artemis Therapeutics Inc.

ATMS
Rank in Stocks #24862
Artemis Therapeutics Inc. currently lacks substantial business operations.... Artemis Therapeutics Inc. currently lacks substantial business operations. Situated in New York, New York, this company previously concentrated on developing pharmaceutical agents to prevent and treat severe and life-threatening infectious diseases. It is a subsidiary of Tonak Ltd.
Share Price
$0.498
Last synced: 2023-05-25
Market Cap
$55.79M
Change (1 day)
-73.65%
Change (1 year)
0.00%
Country
US
Trade Artemis Therapeutics Inc. (ATMS)
Revenue for Artemis Therapeutics Inc. (ATMS)
Revenue in Aug 2026 TTM: 0
According to Artemis Therapeutics Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Artemis Therapeutics Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors